FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness
[11/1/2024] FDA is warning patients and health care professionals not to use drugs compounded and distributed...
FDA is alerting patients and health care professionals about the voluntary withdrawal of Oxbryta from the market due to safety concerns
[9/26/2024] FDA is alerting patients, caregivers, and health care professionals that Oxbryta (voxelotor)...
FDA alerts health care professionals of pregnancy problems associated with thiopurines
[4/29/2024] FDA is alerting health care professionals of the rare risk of intrahepatic cholestasis of...
FDA alerts health care professionals of compatibility issues with prefilled glass syringes and certain Luer-activated valve (LAV) connectors
[11/22/2022] FDA is alerting health care professionals that certain Luer-activated valve (LAV) connectors...
FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs
[11-8-2022] Health care professionals should be cautious of possible xylazine inclusion in fentanyl,...
FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding
[5/25/2022] FDA is alerting customers of North American Custom Laboratories LLC, doing business as FarmaKeio...
FDA alerts patients and health care professionals not to use compounded products intended to be sterile from Prescription Labs Inc. dba Greenpark Compounding Pharmacy
[9/29/2021] Update: FDA is alerting veterinarians and animal owners/caretakers not to use compounded...
FDA alerts patients and health care professionals about clinical trial results showing an increased risk of death associated with Pepaxto (melphalan flufenamide)
[7/28/2021] FDA is alerting patients and Health care professionals that a clinical trial (OCEAN, Study...
FDA advises health care professionals not to use ChloraPrep 3 mL applicators manufactured by BD (Becton, Dickinson and Company)
Update [3/25/2021] FDA is alerting health care professionals of BD’s voluntary recall expansion of...
FDA alerts health care professionals and oncology clinical investigators about efficacy and potential safety concerns with atezolizumab in combination with paclitaxel for treatment of breast cancer
[9/08/2020] FDA is alerting health care professionals, oncology clinical investigators, and patients...
FDA alerts patients and health care professionals of Amneal and Impax Laboratories epinephrine auto-injector device malfunctions
[6/1/2020] FDA is alerting patients, caregivers and health care professionals to immediately inspect...
FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration
Update [4/9/2020] FDA is notifying patients and caregivers that EpiPens are not being recalled at this...
FDA alerts patients and healthcare professionals to Infusion Options’ voluntary recall due to quality issues
[6/21/2019] The U.S. Food and Drug Administration is alerting Healthcare professionals and patients of...
FDA alerts health care professionals and patients not to use drug products intended to be sterile from Promise Pharmacy
Compounded drugs were produced under poor sterile production practices in an inadequately designed processing...
FDA alerts health care professionals and patients not to use sterile drug products from Pharm D Solutions
[11/19/2018] The U.S. Food and Drug Administration is alerting Health care professionals and patients...
FDA alerts patients and health care professionals that some EpiPen auto-injectors may not readily slide out of carrier tube
[11/2/2018] FDA is alerting patients, caregivers and Health care professionals that the labels attached...
FDA advises health care professionals not to use MedGyn Products’ Monsel’s Solution
[6/29/2018] FDA advises health care professionals not to use MedGyn Products’ Monsel’s...
FDA alerts health care professionals, patients, and the drug supply chain not to use stolen fertility drugs, Gonal-f RFF Redi-ject and Gonal-f Multi-Dose
[5/30/2018] FDA is alerting health care professionals, patients, and the drug supply chain of stolen...